BioSpace News Archive

Titan Medical Inc. announced the launch of “Titan Living Labs”, a new media-rich addition to its website providing access to the stories behind the design, engineering and innovative technologies employed by Titan’s engineering team for the Enos™ robotic single access surgical system.

Athersys, Inc., a regenerative medicine company developing MultiStem® cell therapy, announced that Dr. Gil Van Bokkelen has stepped down as Chairman and Chief Executive Officer, effective immediately.

Feb. 16, 2021 12:00 UTC Q4 2020 revenues up 4.6% year-over- Q4 2020 GAAP EPS of $0.45; non-GAAP EPS of $0.58 Expanded Project Accelerate 2.0 in proteomics, spatial biology and molecular diagnostics Strong revenue growth, Non-GAAP margin expansion and EPS growth expected in FY 2021

LumiThera Inc., a commercial stage medical device company offering a photobiomodulation (PBM) treatment for ocular damage and disease, today announced the interim data from the ELECTROLIGHT pilot study in dry AMD patients.

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, announces its participation in the 10 th Annual SVB Leerink Global Healthcare Conferen

Evaxion Biotech A/S, a clinical-stage biotechnology company specializing in the development of AI-driven immunotherapies to improve the lives of patients with cancer and infectious diseases, announced the opening of its new corporate headquarters and research laboratory facility located in the DTU Science Park in Hoersholm near Copenhagen, Denmark.

Generic Pharmaceutical and Contract Manufacturing Industry Leader Joins Teligent Board, Effective Immediately

Salarius Pharmaceuticals, LLC , a clinical-stage biopharmaceutical company developing potential new medicines for patients with pediatric cancers, solid tumors, and other cancers, announced today that it will participate in the BIO CEO & Investor Digital Conference taking place Tuesday, February 16, 2021 to Thursday, February 18, 2021.

InMed Pharmaceuticals Inc. (Nasdaq: INM) (TSX: IN), a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading the clinical development of cannabinol today announced that it has closed the previously

Study of FDA-cleared Concussion Index Evaluates Student Athletes from 10 U.S. Universities and High Schools at Time of Injury, Return to Play, and 45 Days Later